Allogenic bone marrow transplantation: current status and future directions.
D000741:Anemia, Aplastic / Q000628:therapy; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D002469:Cell Separation; D003520:Cyclophosphamide / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D005199:Fanconi Anemia / Q000628:therapy; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D006086:Graft vs Host Disease / Q000150:complications / Q000517:prevention & control; D006562:Herpes Zoster / Q000209:etiology; D006648:Histocompatibility; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008233:Lymphotoxin-alpha / Q000378:metabolism; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000209:etiology; D011247:Pregnancy; D013601:T-Lymphocytes / Q000276:immunology; D014430:Twins, Monozygotic; D014916:Whole-Body Irradiation
D008233:Lymphotoxin-alpha; D003520:Cyclophosphamide; D002066:Busulfan